Hepatitis E Diagnostic Tests Market Size & Share Report, 2032

Hepatitis E Diagnostic Tests Market – By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test, Polymerase Chain Reaction), Sample Type (Blood, Stool), End-use (Hospitals, Diagnostic Laboratories) – Global Forecast 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising hepatitis E incidence

3.2.1.2&nbsp;&nbsp;&nbsp; Advancement in diagnostic technologies

3.2.1.3&nbsp;&nbsp;&nbsp; Rising awareness and screening programs

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Limited availability in developing regions

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory scenario

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.5.1&nbsp;&nbsp;&nbsp; Core technologies

3.5.2&nbsp;&nbsp;&nbsp; Adjacent technologies

3.6&nbsp;&nbsp;&nbsp; Future market trends

3.7&nbsp;&nbsp;&nbsp; Gap analysis

3.8&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTLE analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Test Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; ELISA HEV IgM test

5.3&nbsp;&nbsp;&nbsp; ELISA HEV IgG test

5.4&nbsp;&nbsp;&nbsp; Rapid diagnostics test

5.5&nbsp;&nbsp;&nbsp; Polymerase chain reaction (PCR)

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Sample Type, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Blood

6.3&nbsp;&nbsp;&nbsp; Stool

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-use, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Diagnostic laboratories

7.4&nbsp;&nbsp;&nbsp; Blood banks

7.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; altona Diagnostics GmbH

9.2&nbsp;&nbsp;&nbsp; CTK Biotech, Inc.

9.3&nbsp;&nbsp;&nbsp; Dia.Pro Diagnostic Bioprobes s.r.l

9.4&nbsp;&nbsp;&nbsp; DiaSorin S.p.A.

9.5&nbsp;&nbsp;&nbsp; ELITechGroup ( Bruker company)

9.6&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd

9.7&nbsp;&nbsp;&nbsp; Fortress Diagnostics

9.8&nbsp;&nbsp;&nbsp; Genscript Biotech Corporation

9.9&nbsp;&nbsp;&nbsp; Guangzhou Wondfo Biotech Co., Ltd.

9.10&nbsp;&nbsp;&nbsp; Medsource Ozone Biomedicals Pvt. Ltd.

9.11&nbsp;&nbsp;&nbsp; MIKROGEN GmbH

9.12&nbsp;&nbsp;&nbsp; MP Biomedicals

9.13&nbsp;&nbsp;&nbsp; Primer Design

9.14&nbsp;&nbsp;&nbsp; Wantai BioPharm 
&nbsp;

Hepatitis E Diagnostic Tests Market

Get a free sample of this report